Krishna Vaddi Prelude Therapeutics Inc (PRLD) insider trading activity

PRLD Quotes by TradingView

Krishna Vaddi is CEO of Prelude Therapeutics Inc. Currently has a direct ownership of 1.17 Million shares of PRLD, which is worth approximately $1.52 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 100,000 shares (Common Stock) at a price of $0.93 per share, resulting in proceeds of $93,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.17M
9.37% 3M change
9.37% 12M change
Total Value Held $1.52 Million

Krishna Vaddi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
BUY
Open market or private purchase
$93,000 $0.93 p/Share
100,000 Added 7.89%
1,167,275 Common Stock
May 25 2023
BUY
Open market or private purchase
$4,779 $5.31 p/Share
900 Added 0.08%
1,067,275 Common Stock
May 24 2023
BUY
Open market or private purchase
$5,010 $5.01 p/Share
1,000 Added 0.09%
1,066,375 Common Stock
May 23 2023
BUY
Open market or private purchase
$66,749 $5.63 p/Share
11,856 Added 1.1%
1,065,375 Common Stock
Dec 13 2021
BUY
Grant, award, or other acquisition
$97,040 $12.13 p/Share
8,000 Added 0.75%
1,053,519 Common Stock
KV

Krishna Vaddi

CEO
Wilmington, DE

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if

News

Receive news related to Prelude Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRLD